Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	590	686	332	162	861	-
Market Cap Growth	106.84%	106.84%	105.22%	-81.23%	-	-
Enterprise Value	904	1,086	775	605	1,054	-
Last Close Price	9.51	10.50	5.27	2.61	14.49	-
Forward PE	14.52	20.00	21.82	17.17	21.50	-
PS Ratio	1.07	1.20	0.65	0.32	2.00	-
PB Ratio	4.23	3.70	1.50	0.39	1.61	-
P/FCF Ratio	15.59	18.16	41.57	-	90.94	-
P/OCF Ratio	15.19	17.69	21.63	-	37.46	-
PEG Ratio	-	-	2.07	2.07	-
EV/Sales Ratio	1.58	1.90	1.51	1.18	2.45	-
EV/EBITDA Ratio	15.32	18.42	26.88	-	25.38	-
EV/EBIT Ratio	22.68	27.27	382.69	-	50.07	-
EV/FCF Ratio	23.91	28.75	97.14	-	111.28	-
Debt / Equity Ratio	1.92	1.92	1.90	1.06	0.71	1.42
Debt / EBITDA Ratio	5.50	5.50	11.81	719.64	8.23	3.83
Debt / FCF Ratio	9.42	9.42	52.70	-	39.72	3.70
Asset Turnover	0.75	0.75	0.47	0.39	0.50	0.66
Inventory Turnover	2.01	2.01	2.09	2.47	2.82	3.11
Quick Ratio	0.80	0.80	0.91	0.55	0.93	1.43
Current Ratio	1.31	1.31	1.53	0.90	1.46	1.73
Return on Equity (ROE)	-21.55%	-21.55%	-38.27%	-30.58%	3.38%	10.16%
Return on Assets (ROA)	3.24%	3.24%	0.12%	-1.67%	1.53%	2.82%
Return on Capital (ROIC)	4.21%	4.21%	0.17%	-2.46%	2.09%	3.84%
Return on Capital Employed (ROCE)	7.70%	7.70%	0.30%	-	2.00%	5.90%
Earnings Yield	-5.69%	-4.89%	-47.08%	-98.15%	2.25%	-
FCF Yield	6.41%	5.51%	2.40%	-15.50%	1.10%	-
Payout Ratio	0.00%	-	-	-	-	121.18%
Buyback Yield / Dilution	-3.03%	-3.03%	-2.05%	-35.00%	-828.01%	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q